Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bailard Inc.’s Top Stock Picks

Thomas Bailard’s Bailard Inc. made a lot of changes to its portfolios. Here is a summary of its recent changes:

Apple Inc. (AAPL)

Bailard reduced his portfolio from $504 million at the end of June to $433 million at the end of the third quarter. Bailard also reduced the number of his positions. He had had 215 positions at the end of June and now has just 186 positions. Bailard has sold out Eli Lilly & Co (LLY) and Costco (COST). It seems Bailard made the right decision to sell these two stocks. LLY returned 3.18% and COST returned 3.15% since the end of September, both underperforming SPY by eight percentage points. Bailard also slashed his stake in PPL Corp (PPL), Alkermes Inc (ALKS), Mack Cali Realty Corp (CLI), and Insulet Corp (PODD).

Bailard increased his position in Apple Inc (AAPL). Bailard disclosed to own $4.9 million worth of the stock at the end of September, up 111% from the end of June. Though AAPL only returned 1.97% since the end of September, the stock has a YTD return of 17.98%, beating the SPY by 11 percentage points. Bailard also upped his stake in Pfizer Inc (PFE) by 489% to $2.1 million. PFE returned 13.54% since the end of third quarter.

(Read the rest of the article here)